[Pharmaceutical intervention in duration of antimicrobial treatment at hospital ambit]

M Morante1, C Matoses-Chirivella, F J Rodríguez-Lucena

  • 1María Morante Hernández, Servicio de Farmacia, Hospital General Universitario de Elche, Camino de la Almazara, s/n, 03203, Elche (Alicante), Spain. maria.morante@uv.es.

Abstract

Insights

Pharmacist interventions to shorten antimicrobial therapy duration were accepted by physicians, leading to reduced antimicrobial use. Further improvements are needed, but the program shows promise in optimizing antibiotic treatment and lowering healthcare costs.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Hospital Pharmacy

Background:

  • Antimicrobial resistance necessitates optimizing antibiotic therapy duration.
  • Prolonged antibiotic use increases risks and costs.
  • Pharmaceutical interventions can improve antimicrobial stewardship.

Purpose of the Study:

  • To assess physician acceptance of pharmacist recommendations on antimicrobial therapy duration.
  • To evaluate the impact of these interventions on antimicrobial consumption and Clostridium difficile incidence.

Main Methods:

  • Prospective observational study over two years in a university hospital.
  • Interventions targeted adult patients with non-compliant antimicrobial treatment durations.
  • Physicians were consulted to reassess the need for continued antibiotic therapy.

Main Results:

  • Pharmacist interventions occurred in 122 patients, primarily for prolonged β-lactam use (meropenem).
  • Physician acceptance of recommendations to suspend treatment was 65.95% for oral and 65.00% for written interventions.
  • Antimicrobial consumption (DDD) decreased by 8.89%, and expenditure by 40.12%, with stable C. difficile incidence.

Conclusions:

  • Pharmaceutical counseling on antimicrobial therapy duration is accepted by prescribers but requires enhancement.
  • Information delivery method (oral vs. written) did not impact acceptance rates.
  • These interventions can significantly reduce antimicrobial consumption and associated costs.

Related Concept Videos

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration01:23

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s...
138
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.3K
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to...
553
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
972
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
80
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
257